Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electronic Patient Reporting of Side Effects to Chemotherapy Among Breast Cancer Patients Using the Patient-Reported Outcomes Version of Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Cluster Randomized Controlled Trial

NCT02996201 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT02996201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electronic Patient Reporting of Side Effects to Chemotherapy Among Breast Cancer Patients Using the Patient-Reported Outcomes Version of Common Terminology Criteria for Adverse Events (PRO-CTCAE): A Cluster Randomized Controlled Trial
Lead sponsor
Rigshospitalet, Denmark
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
January 31, 2017
Enrollment
700 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event, cancer, breast, chemotherapeutic toxicity, patient outcomes assessments